444 results on '"Vlachoyiannopoulos, Panayiotis"'
Search Results
2. A randomized clinical trial of bermekimab treatment for clinical improvement of systemic sclerosis
3. Computational Methods for Anticancer Drug Discovery; The MCT4 Paradigm
4. Antiphospholipid antibodies induce proinflammatory and procoagulant pathways in endothelial cells
5. Autoimmune Rheumatic Disorders: Pathogenetic and Laboratory Aspects
6. Basic Immunology
7. Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study
8. Helicobacter pylori Eradication Reverses DNA Damage Response Pathway but Not Senescence in Human Gastric Epithelium
9. COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review
10. Medications, Therapeutic Modalities, and Regimens Used in the Management of Rheumatic Diseases
11. Rheumatic Manifestations: A Compilation
12. Rheumatic Disorders Associated with Metabolic, Endocrine, and Hematological Diseases
13. Bone, Cartilage, and Soft Tissue Disorders
14. The Skin, the Eyes, and the Ears in Rheumatic Diseases
15. Sjögren’s Syndrome, IgG4-Related Disorders
16. Autoinflammatory Syndromes
17. Vasculitides and Related Diseases
18. Inflammatory Muscle Disease
19. Systemic Sclerosis
20. Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Mixed Connective Tissue Disease
21. Inflammatory Arthritides
22. Autoimmune Rheumatic Disorders: Pathogenetic and Laboratory Aspects
23. Basic Immunology
24. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
25. Autoimmune Rheumatic Disorders: Pathogenetic and Laboratory Aspects
26. Basic Immunology
27. NMR-based metabolomics in giant cell arteritis and polymyalgia rheumatica sequential sera differentiates active and inactive disease
28. Natural Proteins Involved in Antiphospholipid Syndrome
29. Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves’ orbitopathy: an observational study
30. Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients
31. Drug-Induced Podocytopathies: Report of Four Cases and Review of the Literature
32. Acute Renal Vein Thrombosis Following COVID-19 in a Lupus Patient: A Case Report and Review of the Literature
33. Rheumatology in Questions
34. Large Vessel Vasculitis After the Administration of Oxford-AstraZeneca COVID-19 Vaccine
35. The Role of the Akt Signaling Pathway in Sjögren’s Syndrome
36. Oral Antiviral Treatment for COVID-19 in Patients With Systemic Autoimmune Rheumatic Diseases
37. Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study
38. What are the Target Cells and Receptors that are Recognized by Antiphospholipid Antibodies?
39. Small airways dysfunction in patients with systemic sclerosis and interstitial lung disease
40. Congruence and Complementarity of Differential Mobility Spectrometry and NMR Spectroscopy for Plasma Lipidomics
41. Oral Antiviral Treatment for COVID-19 in Patients With Systemic Autoimmune Rheumatic Diseases.
42. Presence of antiphospholipid antibodies is associated with increased implantation failure following in vitro fertilization technique and embryo transfer: A systematic review and meta-analysis
43. COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases
44. Mapping and predicting mortality from systemic sclerosis
45. 08.35 Thrombospondin-1 is elevated in the plasma of patients with antiphospholipid syndrome and is correlated with free active tgf-b1 levels, il-1b and il-17a
46. 02.02 Pharmaceutical disruption of B2GPI CXCL4 complex using computationally designed oligopeptides
47. Late and booster anti‐SARS‐CoV ‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al
48. Incidence of autoantibodies related to systemic autoimmunity in patients with severe COVID-19 admitted to the intensive care unit
49. Hashimoto Thyroiditis, Anti-Parietal Cell Antibodies: Associations With Autoimmune Diseases and Malignancies
50. Detection of Autoantibodies to Extractable Cellular Antigens
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.